Koya’s NPCD device proves more effective than APCDs in lymphedema
The TEAYS study’s lead investigator and associate professor of surgery at the University of Tennessee Health Science Center Michael Barfield said: “The introduction of Dayspring represents a clinically differentiated and therapeutically distinct advancement in the treatment of lower extremity lymphedema.